by Madaline Spencer | Sep 3, 2025
Margarita Ochoa-Maya, MD, Medical Director of the Rare Disease Business Unit at Amgen, discusses the TEDucation campaign for thyroid eye disease (TED). TED is a rare autoimmune disease that can dramatically impact a person’s vision. The condition often occurs...
by Madaline Spencer | Sep 1, 2025
Lori Bulpett, Manager of Patient Advocacy at Chiesi Global Rare Diseases, discusses mental health in patients with acromegaly. Acromegaly is a hormonal disorder that results from the overproduction of growth hormone in the pituitary gland. It is most...
by Madaline Spencer | Aug 29, 2025
Tracey Dawson, PhD, SVP, U.S. Therapeutic Area Head of Neuroscience at Novartis, discusses the SMAshing My Limits campaign. Spinal muscular atrophy (SMA) is a group of genetic neuromuscular disorders that affect the motor neurons. The loss of motor...
by Madaline Spencer | Aug 26, 2025
Jason Crompton, PharmD, Global Medical Director of the Acromegaly Program at Chiesi Rare Diseases, discusses disparities between biochemical control and symptom burden in patients with acromegaly. Acromegaly is a hormonal disorder that results from the...
by Madaline Spencer | Aug 25, 2025
Mohamed Ladha, President and General Manager for Recordati Rare Diseases North America, discusses the company’s rare disease initiatives. The U.S. branch of Recordati was established in 2013 with a focus on products to treat patients with rare inherited...